Allergy medication recalled over potentially ‘life-threatening’ cross-contamination
Cetirizine, a generic version of Zyrtec, is being recalled in the US due to potentially life-threatening ranitidine contamination.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Bottles of cetirizine antihistamine tablets are being recalled in the United States. The recall was triggered after the medication was found to be contaminated with ranitidine.
Coverage from The Hill and Miami Herald describes the cross-contamination as potentially deadly and life-threatening. Other reports from USA Today, Laredo Morning Times, and Citeline focus on the specific drugs involved and the availability of lists for affected products.
Future developments will likely center on the identification of the specific affected products as highlighted by USA Today.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
Which medication is being recalled?
Cetirizine, which is a generic version of Zyrtec, is being recalled.
What caused the recall?
The recall is due to the contamination of cetirizine with ranitidine.
What are the risks associated with this contamination?
The Hill and Miami Herald report that the cross-contamination could be life-threatening or deadly.
Coverage (5)
- Ranitidine Contaminates Cetirizine In US Recall insights.citeline.com · 8h ago
- Cetirizine, generic Zyrtec, recalled over ranitidine contamination Laredo Morning Times · 8h ago
- Contamination of one antihistamine by another could be deadly. There’s a recall Miami Herald · 8h ago
- Bottles of antihistamine tablets recalled. See the affected products USA Today · 8h ago
- Allergy medication recalled over potentially ‘life-threatening’ cross-contamination The Hill · 8h ago
Topics
Related trends
Charles Schwab Earnings: Why Stock Is Falling Despite Faster Growth
Charles Schwab reports record revenue and earnings beats, yet shares face downward pressure due to rising expenses.
CVS announces new pharmacy option for pet owners
CVS Pharmacy is expanding its service offerings to include prescription medications for pets.
AMD just landed its biggest AI deal yet
Treasury Flags Concern Over ‘Potentially Abusive’ Tax Trades
The US Treasury is warning Wall Street and hedge funds that certain 'tax alpha' strategies may be potentially abusive.
SpaceX’s stock looks to snap brutal losing streak as it heads for one of its best days yet
SpaceX shares are rebounding and snapping a losing streak following the announcement of the company's first earnings date.
OpenAI appoints two new members to board of directors
OpenAI has expanded its board of directors by appointing top banking and fintech executives as the company moves toward a potential IPO.